References
- Beedham, C. (1985) Molybdenum hydroxylases as drug-metabolizing enzymes. Drug Metab. Rev. 16, 119-156. https://doi.org/10.3109/03602538508991432
- Beedham, C. (1987) Molybdenum hydroxylases: Biological distribution and substrate-inhibitor specificity. Prog. Med. Chem. 24, 85-121. https://doi.org/10.1016/S0079-6468(08)70420-X
- Beedham, C. (1997) The role of non-P450 enzymes in drug oxidation. Pharm. World Sci. 19, 255-263. https://doi.org/10.1023/A:1008668913093
- Beedham, C. (1998) Molybdenum hydroxylases; in Metabolism of Xenobiotics, Gorrod, J. W., Oeschlager, H., and Caldwell, J. (eds), pp. 51-58, Taylor and Francis, London and New York, USA.
- Beedham, C. (2002) Molybdenum hydroxylase; in Enzyme Systems that Metabolise Drug and Other Xenobiotics, Ioannides, C. (ed.), pp. 147-187, John Wiley, Chichester, UK.
- Beedham, C., Miceli, J. J. and Obach, S. (2003) Ziprasidone metabolism, aldehyde oxidase, and clinical implications. J. Clin. Psychopharm. 23, 229-232. https://doi.org/10.1097/00004714-200306000-00003
- Glueksohn-Waelsch, S., Greengard, P., Quinn, G. P. and Teicher, L. S. (1967) Genetic variations of an oxidase in mammals. J. Biol. Chem. 242, 1271-1273.
- Huang, D. Y., Furukawa, A. and Ichikawa, Y. (1999) Molecular cloning of retinal oxidase/aldehyde oxidase cDNA from rabbit and mouse liver and functional expression of recombinant mouse retinal oxidase cDNA in Escherichia coli. Arch Biochem. Biophys. 364, 264-272. https://doi.org/10.1006/abbi.1999.1129
- Itoh, K., Yamamura, M., Muramatsu, S., Hoshino, K., Masubuchi, A., Sasaki, T. and Tanaka, Y. (2005) Stereospecific oxidation of (S)-enantiomer of RS-8359, a selective and reversible MAO-A inhibitor, by aldehyde oxidase. Xenobiotica 35, 561-573. https://doi.org/10.1080/00498250500202106
- Itoh, K., Yamamura, M., Takasaki, W., Sasaki, T., Masubuchi, A. and Tanaka, Y. (2006) Species differences in enantioselective 2-oxidation of RS-8359, a selective and reversible MAO-A inhibitor, and cinchona alkaloids by aldehyde oxidase. Biopharm. Drug Dispos. 27, 1133-1139.
- Itoh, K., Masubuchi, A., Sasaki, T., Adachi, M., Watanabe, N., Nagata, K., Yamazoe, Y., Hiratsuka, M., Mizugaki, M. and Tanaka, Y. (2007) Polymorphism of aldehyde oxidase in Donryu rats. Drug Metab. Dispos. 35, 734-739. https://doi.org/10.1124/dmd.106.011502
- Iwata, N., Tonohiro, T., Kozuka, M., Kumagae, Y., Takasaki, W. and Tanaka, Y. (1996) A novel selective and reversible MAO-A inhibitor, RS-8359: its pharmacological properties and metabolism. Int. Acad. Biomed. Drug Res. 11, 285-286.
- Jordan, C. G. M., Rashidi, M. R., Laljee, H., Clarke, S. E., Brown, J. E. and Beedham, C. (1999) Aldehyde oxidase-catalyzed oxidation of methotrexate in the liver of guinea pig, rabbit and man. J. Pharm. Pharmacol. 51, 411-418. https://doi.org/10.1211/0022357991772619
- Kitamura, S., Sugihara, K., Nakatani, K., Ohta, S., O'Hara, T., Nimomiya, S., Green, C. E. and Tyson, C. A. (1999a) Variation of hepatic methotrexate 7-hydroxylase activity in animals and humans. IUBMB Life. 48, 607-611. https://doi.org/10.1080/713803569
- Kitamura, S., Nakatani, K., Sugihara, K., and Ohta, S. (1999b) Strain differences of the ability to hydroxylate methotrexate in rats. Com. Biochem. Phys. Part C 122, 331-336. https://doi.org/10.1016/S1095-6433(99)00014-8
- Kitamura, S., Sugihara, K. and Ohta, S. (2006) Drug-metabolizing ability of molybdenum hydroxylases. Drug Metab. Pharmacokinet. 21, 83-98. https://doi.org/10.2133/dmpk.21.83
- Kumagae, Y., Matsui, Y. and Iwata, N. (1991) Deamination of norepinephrine, dopamine, and serotonin by type A monoamine oxidase in discrete regions of the rat brain and inhibition by RS-8359. Jpn. J. Pharmacol. 55, 121-128. https://doi.org/10.1254/jjp.55.121
- Miura, H., Naoi, M., Nakahara, D., Ohta, T. and Nagatsu, T. (1993) Changes in monoamine levels in mouse brain elicited by forcedswimming stress, and the protective effect of a new monoamine oxidase inhibitor, RS-8359. J. Neural Transm. 94, 175-187. https://doi.org/10.1007/BF01277023
- Plenker, A., Puchler, K. and Volz, H. P. (1997) The effects of RS- 8359 on cardiovascular function in healthy subjects and depressed patients. Int. Clin. Psychopharm. 12, S25-S29.
- Prakash, C., Kamel, A., Gummerus, J. and Wilner, K. (1997) Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans. Drug Metab. Dispos. 25, 863-875.
- Puchler, K., Schaffler, K. and Plenker, A. (1997) The comparative effects of single and multiple doses of RS-8359, moclobemide and placebo on psychomotor function in healthy subjects. Int. Clin. Psychopharm. 12, 17-23.
- Rashidi, M. R., Smith, J. A., Clarke, S. E. and Beedham, C. (1997) In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit and rat liver. Drug Metab. Dispos. 25, 805-813.
- Sasaki, T., Masubuchi, A., Yamamura, M., Watanabe, N., Hiratsuka, M., Mizugaki, M., Itoh, K. and Tanaka, Y. (2006) Rat strain differences in stereospecific 2-oxidation of RS-8359, a reversible and selective MAO-A inhibitor, by aldehyde oxidase. Biopharm. Drug Dispos. 27, 247-255. https://doi.org/10.1002/bdd.504
- Sugihara, K., Kitamura, S. and Tatsumi, K. (1995) Strain differences of liver aldehyde oxidase in rats. Biochem. Mol. Biol. Int. 37, 861-869.
- Takasaki, W., Yamamura, M., Nozaki, A., Nitanai, T., Sasahara, K., Itoh, K. and Tanaka, Y. (2005) Stereoselective pharmacokinetics of RS-8359, a selective and reversible MAO-A inhibitor, by species-dependent drug metabolizing enzymes. Chirality 17, 135-141. https://doi.org/10.1002/chir.20124
- Wright, R. M., Clayton, D. A., Riley, M. G., McManaman, J. L. and Repine, J. E. (1999) cDNA cloning, sequencing, and characterization of male and female rat liver aldehyde oxidase (rAOX1). J. Biol. Chem. 274, 3878-3886. https://doi.org/10.1074/jbc.274.6.3878
- Yamaguchi, Y., Matsumura, T., Ichida, K., Okamoto, K. and Nishino, T. (2007) Human xanthine oxidase changes its substrate specificity to aldehyde oxidase type upon mutation of amino acid residues in the active site: role of active site residues in binding and activation of purine substrate. J. Biochem. 141, 513-524. https://doi.org/10.1093/jb/mvm053
- Yokoyama, T., Karube, T. and Iwata, N. (1989) Comparative studies of the effects of RS-8359 and safrazine on monoamine oxidase in vitro and in vivo in mouse brain. J. Pharm. Pharmacol. 41, 32-36. https://doi.org/10.1111/j.2042-7158.1989.tb06324.x
Cited by
- Optimization of the Expression of Human Aldehyde Oxidase for Investigations of Single-Nucleotide Polymorphisms vol.44, pp.8, 2016, https://doi.org/10.1124/dmd.115.068395
- Functional Analysis of Aldehyde Oxidase Using Expressed Chimeric Enzyme between Monkey and Rat vol.32, pp.1, 2009, https://doi.org/10.1248/bpb.32.31
- Structure and function of mammalian aldehyde oxidases vol.90, pp.4, 2016, https://doi.org/10.1007/s00204-016-1683-1
- In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor vol.11, pp.1, 2011, https://doi.org/10.1038/tpj.2010.8
- Individual and Strain Difference of Aldehyde Oxidase in Rat vol.129, pp.12, 2009, https://doi.org/10.1248/yakushi.129.1487
- The role of aldehyde oxidase in drug metabolism vol.8, pp.4, 2012, https://doi.org/10.1517/17425255.2012.663352